SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria

Denitsa Tsaneva-Damyanovaa Medical Diagnostic Laboratory, “STATUS”, Varna, Bulgaria;b Department of Microbiology and Virology, Faculty of Medicine, Medical University of Varna, Varna, BulgariaCorrespondence[email protected]

https://orcid.org/0000-0002-0664-374X View further author information

Pages 441-446 | Received 22 Apr 2020, Accepted 18 May 2020, Published online: 27 May 2020

Cite this article
https://doi.org/10.1080/13102818.2020.1772105
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

WHO-World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Google Scholar
Chu D, Pan Y, Cheng S, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020;66(4):549–555.
PubMed Web of Science ®Google Scholar
Coleman C, Frieman MB. Coronaviruses: important emerging human pathogens. J Virol. 2014; 88(10):5209–5212.
PubMed Web of Science ®Google Scholar
Yang L, et al. Novel SARS-like betacoronaviruses in bats, China. Emerg Infect Dis. 2011; 19:989–991.
Web of Science ®Google Scholar
Hu B, et al. Discovery of a rich gene pool of bats SARS-related coronaviruses provides new insights into origin of SARS coronavirus. Plos Pathol. 2017; 13(11):e-1006698.
Web of Science ®Google Scholar
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probate bat origin. Nature. 2020;579(7798):270–273.
PubMed Web of Science ®Google Scholar
Yuen K-S, Ye Z-W, Fung S-Y, et al. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10:40.
PubMed Web of Science ®Google Scholar
Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406.
PubMed Web of Science ®Google Scholar
Chin A, Chu TS, Perera MRA, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020.
PubMedGoogle Scholar
Kellam P, Barcley W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. Preprints (www.preprints.org). 2020.
Google Scholar
Zhou L, Ruan F, Huang M, еt al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. NEJM. 2020;382:1177–1179.
PubMed Web of Science ®Google Scholar
Gallagher G. Dealing with false negative Covid-19 test results. Contagion Live.Infectious diseases today (article). 2020. https://www.contagionlive.com/news/dealing-with-false-negative-covid19-test-results.
Google Scholar
West CP, Montori VM, Sampathkumar P. COVID-19 testing: the threat of false-negative results. MCP: Mayo Clin Proc. 2020. https://doi.org/10.1016/j.mayocp.2020.04.004.
Web of Science ®Google Scholar
Zhao J, Yuan Q, Wang H, et al. Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019 (February 25, 2020). Available from: https://ssrn.com/abstract=3546052. http://dx.doi.org/10.2139/ssrn.3546052.
Google Scholar
Zhou F, Fan G, Liu Z, et al. SARS-CoV-2 shedding and infectivity – authors’ reply. The Lancet. 2020;395(10233):1340.
PubMed Web of Science ®Google Scholar
Pinto D, Park YJ, Beltramello M, et al. Structural and functional analysis of a potent sarbecovirus neutralizing antibody. bioRxiv.2020.04.07.023903.
Google Scholar
Wu F, Wang A, Liu M, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. MedRXiV. 2020. doi: https://doi.org/10.1101/2020.03.30.20047365.
Google Scholar
Duan K, Lui B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. PNAS. 2020;117(17):9490–9496. http://doi.org.10.1073/pnas.2004168117.
Web of Science ®Google Scholar
Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582.
PubMed Web of Science ®Google Scholar
Bao L, Deng W, Gao H, et al. Reinfection could not occur in SARS-COV-2 infected rhesus macaques. bioRxiv. 2020; Preprint; doi:.
Google Scholar
Long Q, Lui BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020. http://doi.rg/10.1038/s41591-020-0897-1.
Web of Science ®Google Scholar
Forgey Q. Politico magazine. 04/10/2020; https://www.politico.com/news/2020/04/10/fauci-coronavirus-immunity-cards-for-americans-are-being-discussed-178784.
Google Scholar
Griffin D. The immune response in measles: virus control, clearance and protective immunity. Viruses. 2016;8(10):282.
PubMed Web of Science ®Google Scholar
Wu L-P, Wang N-C, Chang Y-H, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564.
PubMed Web of Science ®Google Scholar
Poh CM, Carissimo G, Wang B, et al. Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitops on the SARS-COV-2 spike protein. bioRxiv. 2020; Preprint;.
Google Scholar
Alshukairi AN, et al. Antibody response and disease severity in healthcare worker MERS survivors. Emerg Infect Dis. 2016;22(6):1113–1115.
Web of Science ®Google Scholar
Streck H, Hartmann G, Exner M, et al. Vorläufiges Ergebnis und Sshlussfolgerungen der COVID-19 case-cluster-study (Gemeinde Gangeit). 2020. University of Bonn. non-peer reviewed report. https://hallespektrum.de/nachrichten/bildung/erste-ergebnisse-der-corona-studie-von-prof-streek-in-heinsberg/373118/.
Google Scholar
Sutton D, Fuchs K, D’Alton M, et al. Correspondence. Universal screening for SARS-CoV-2 in women admitted for delivery. N Eng J Med. 2020. http://www.nejm.org/doi/full/10.1056/NEJMc2009316.
PubMed Web of Science ®Google Scholar
Gudbjartsson D, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in Icelandic population. N Eng J Med. 2020. http://www.nejm.org/doi/full/10.1056/NEJMoa2006100.
PubMed Web of Science ®Google Scholar
Galazka A, et al. The immunological basis for immunization series module 1: general immunology. WHO/EPI/GEN/93.11.1993:10; https://apps.who.int/iris/bitstream/handle/10665/58891/WHO_EPI_GEN_93.11_mod1.pdf?sequence=1&isAllowed=y.
Google Scholar
Wiedermann U, Garner-Spitzer E, Wagner A, et al. Primary vaccine failure to routine vaccines: why and what to do? Hum Vaccin Immunother. 2016;12(1):239–243.
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

SARS-CoV-2: seroepidemiological pattern in northeastern Bulgaria

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date